Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (251-260 of 257) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 257 results.
Cancer Research|September 21, 2017
New Advances and Challenges of Targeting Cancer Stem CellsNurmaa K Dashzeveg, Rokana Taftaf, Erika K Ramos, et al.
The Journal of Clinical Investigation|October 22, 2024
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical modelsTing-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Hematology (Amsterdam, Netherlands)|January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology|July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology|March 9, 2016
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomesAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Nature Communications|November 19, 2020
Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammationDavid R Sweet, Neelakantan T Vasudevan, Liyan Fan, et al.
Science (New York, N.Y.)|June 13, 2015
TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regenerationYongyou Zhang, Amar Desai, Sung Yeun Yang, et al.
Pageof 26

Showing results (251-260 of 257) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 257 results.
Cancer Research|September 21, 2017
New Advances and Challenges of Targeting Cancer Stem CellsNurmaa K Dashzeveg, Rokana Taftaf, Erika K Ramos, et al.
The Journal of Clinical Investigation|October 22, 2024
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical modelsTing-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Hematology (Amsterdam, Netherlands)|January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology|July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology|March 9, 2016
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomesAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Nature Communications|November 19, 2020
Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammationDavid R Sweet, Neelakantan T Vasudevan, Liyan Fan, et al.
Science (New York, N.Y.)|June 13, 2015
TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regenerationYongyou Zhang, Amar Desai, Sung Yeun Yang, et al.
Pageof 26